Results 251 to 260 of about 131,241 (336)

Identification of prognostic biomarkers for endometrioid endometrial carcinoma based on the miRNA and mRNA co-expression network regulated by estradiol. [PDF]

Clinics (Sao Paulo)
Xie Q, Huang J, Xie Y, Hu J, Jin L.
europepmc   +1 more source

Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches

MedComm – Future Medicine, Volume 4, Issue 3, September 2025.
Mitochondria play a critical role in aging and aging‐related diseases. This review systematically explores the mechanisms underlying mitochondrial deterioration during aging and highlights innovative therapeutic strategies for these mitochondrial problems.
Lanlan Jia, Ziyu Wei, Jinyuan Luoqian, Xi Wang, Chao Huang   +4 more
wiley   +1 more source

Follow-up of hereditary endometrial carcinoma caused by <i>MLH3</i> gene mutation: a case report. [PDF]

Front Oncol
Zhang C, Ye J, Li Q, Zhan J, Yang D, Li J, Li T, Wan T.   +7 more
europepmc   +1 more source

Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability

, 2000
Lluís Catasús, Xavier Matías‐Guiu, Pilar Fernández Machín, Gian Franco Zannoni, Giovanni Scambia, Pierluigi Benedetti Panici, Jaime Prat   +6 more
openalex   +1 more source

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun, Dan Huang, Huiling Zhang, Mingyuan Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li, Zhaogang Yang   +10 more
wiley   +1 more source

Study on the expression of S100A4 and HMGA1 in endometrial carcinoma and their correlation with metastasis. [PDF]

Am J Transl Res
Pei X, Nie H, Liu Q, Xu C.
europepmc   +1 more source

Pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients following adjuvant chemotherapy alone: implications for locoregional radiation therapy

, 2000
Arno J. Mundt, Russell B. McBride, Philip P. Connell   +2 more
openalex   +1 more source

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]

, 2019
Cripe, James C, Fuh, Katherine C, Litz, Taylor, Lopez, Heather, Mills, Kathryn A, Mutch, David G, Powell, Matthew A, Sun, Lulu, Thaker, Premal H   +8 more
core   +1 more source

The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancer

International Journal of Cancer, Volume 157, Issue 4, Page 599-613, 15 August 2025.
Abstract Increasing evidence links the gut microbiome to carcinogenesis. Disruptions in estrogen regulation by the estrobolome—gut microbiota with estrogen‐related functions—may promote breast cancer. However, precise information on estrobolome targets and their underlying mechanisms is limited. This review identifies relevant targets for measuring the
Ashley H. Larnder, Amee R. Manges, Rachel A. Murphy   +2 more
wiley   +1 more source

17beta-estradiol (E2) Regulates Malignancies and Stemness in Endometrial Carcinoma (EC) via Interacting with ESR1. [PDF]

Reprod Sci
Xu X, Dai X, Huang C, Guan X, Zhang C.
europepmc   +1 more source